Skip to main content
Ira Goldberg, MD, Endocrinology, New York, NY

IraJayGoldbergMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Diabetes, and Metabolism

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goldberg's full profile

Already have an account?

  • Office

    530 1st Avenue
    Suite 5E
    New York, NY 10016
    Phone+1 212-481-1350

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1975
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyB.S., 1971

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Member Association of American Physicians, 1999
  • Merck Frost Visiting Professor McGill University, 2009
  • Richard Lewar Centre of Excellence in Cardiovascular Research, Distinguished Visiting Professor University of Toronto, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?  
    Heinecke JW, Goldberg IJ, Diabetes, 1/1/2014
  • Cardiac Metabolic Compensation to Hypertension Requires Lipoprotein Lipase  
    Yamashita H, KG. Bharadwaj, S Ikeda, T-S Park, IJ Goldberg, A J Physio, Endo/Metab, 1/1/2008
  • In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation  
    Takahashi M, M Yokoyama, Y Hiyama, Y Hu, K Melford, A Bensadoun, IJ Goldberg, ATVB, 1/1/2008
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Diabetes and Hypertriglyceridemia: Cardiovascular Risk, Mechanisms, and Indications for Treatment 
    ENDO 2019 - New Orleans, LA - 3/26/2019
  • Hepatic Substrate Metabolism and Cardiometabolic Disease 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
  • Endocrinology Board Review, Endocrinology Society 
    San Francisco - 9/2/2014
  • Join now to see all

Press Mentions

  • Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart Disease
    Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 3rd, 2024
  • Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart Disease
    Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 2nd, 2024
  • Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
    Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3November 4th, 2020
  • Join now to see all

Grant Support

  • Diabetes-Mediated Effects On Myeloid Precursors And Vascular ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2012
  • Nutritional And Hormonal Pathways For Reduction Of Apob-LipoproteinsNational Heart, Lung, And Blood Institute2012
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2010–2011
  • Hyperglycemia, Aldose Reductase And Murine AtherosclerosisNational Heart, Lung, And Blood Institute2006–2010
  • Creating Glucose Responsive Cardiovascular ComplicationsNational Heart, Lung, And Blood Institute2006–2010
  • Mechanisms Of Fatty Acid Uptake By Cardiac MuscleNational Heart, Lung, And Blood Institute2003–2010
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2000–2009
  • Role Of Leptin In Atherosclerosis And Arterial InjuryNational Heart, Lung, And Blood Institute2006–2007
  • Vascular Effects Of Heparan Sulfate ProteoglycansNational Heart, Lung, And Blood Institute2002–2006
  • Hyperglycemia, Aldose Reducatse &Murine AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Atherogenicity Of APOB Containing LipoproteinsNational Heart, Lung, And Blood Institute1999–2003
  • Lipolysis, Lipoprotein Lipase And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
  • Extracellular Regulation Of Lipoprotein LipaseNational Heart, Lung, And Blood Institute1995–1999
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute1991–1994

Professional Memberships